| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022545 |
| Receipt No. | R000025980 |
| Official scientific title of the study | Feasibility study investigating the efficacy and safety of hybeid endoscopic submucosal dissection |
| Date of disclosure of the study information | 2016/06/01 |
| Last modified on | 2019/02/20 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Feasibility study investigating the efficacy and safety of hybeid endoscopic submucosal dissection | |
| Title of the study (Brief title) | Efficacy and safety of Hybrid-ESD | |
| Region |
|
|
| Condition | ||
| Condition | Colorectal adenoma/intramucosal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the safety and efficacy of Hybrid-ESD for the treatment of colorectal adenoma/cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Complication rate
assessed after endoscopic treatment |
| Key secondary outcomes | Procedure time, The rate of adverse events (perforation, delayed bleeding)
These autcomes were assessed one Month after the treatment |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients with 20-30mm colorectal adenoma/intramucosal cancer were considered eligible.
Hybrid ESD was performed using newly-developed device which enable scircumferential incision and submucosal dissection. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with 20-30mm colorectal adenoma/intramucosal cancer were consequentially enrolled in the present study.
|
|||
| Key exclusion criteria | We exclude patients with colorectal adenoma/intramucosalcancer larger than 30mm.
Patients whose lesions were found to be outside the guideline or expanded criteria for ESD by the endoscopic characteristics and histological findings of biopsy specimens. Patients in disagreement with informed consent |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Ken Ohata |
| Organization | NTT Medical Center Tokyo
|
| Division name | Department of Gastroenterology |
| Address | 5-9-22 Higashi-gotanda Shinagawa-ku, Tokyo 141-8625, Japan |
| TEL | +81-3-3448-6111 |
| ken.ohata1974@gmail.com | |
| Public contact | |
| Name of contact person | Eiji Sakai |
| Organization | NTT Medical Center Tokyo |
| Division name | Department of Gastroenterology |
| Address | 5-9-22 Higashi-gotanda Shinagawa-ku, Tokyo 141-8625, Japan |
| TEL | +81-3-3448-6111 |
| Homepage URL | |
| eiji525@yokohama-cu.ac.jp | |
| Sponsor | |
| Institute | NTT Medical Center Tokyo
Department of Gastroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | This study do not need financial support |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025980 |